Figure 2From: Impact of currently prescribed lipid-lowering drugs on plasma PCSK9 concentration: single or in combination study in ratsMean percentage changes from placebo in PCSK9 levels during the treatment with ezetimibe, Xuezhikang, Xuezhikang plus ezetimibe, pitavastatin and pitavastatin plus ezetimibe. XZK: Xuezhikang.Back to article page